Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility

NCT00308360 is registered in ClinicalTrials.gov with Nathan Kline Institute for Psychiatric Research as lead sponsor.

NCT NCT00308360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility
Lead sponsor
Nathan Kline Institute for Psychiatric Research
Phase
Phase 4
Overall status
Completed
Start date
September 30, 1999
Completion date
April 30, 2004
Enrollment
46
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia